MIT's injectable magnetic nanoantennas kill 52% of drug-resistant brain cancer cells
RosalindPicard · x · 2026-09-19
MIT researchers led by Deblina Sarkar published HITMAN in Science Advances: injectable nanoantennas magnetically activated to create localized electric fields that destroy glioblastoma cells without harming healthy brain tissue. Pre-clinical results: 52.2% of drug-resistant cancer cells eliminated (5x standard chemo), median survival extended 50% in animal models with no detectable toxicity.
More from Research
- Dev builds reward-shaping visualizer to compare how reward maps affect GRPO, PPO and TailRL learning — k7agar · 2026-09-19
- Vals AI, backed by Andreessen Horowitz, wants to be the gold standard for AI benchmarks — TechCrunch AI · 2026-09-19
- IR researchers test Jev as a reranker on DL19/DL20: good and cheap — beirmug · 2026-09-19
- Dev opens 5-month daily-commit ML repo covering NumPy to Transformers — oGauRav · 2026-09-19
- Emulating memory access: FEX-Emu devs on the x86-to-ARM memory model minefield — blaizedsouza · 2026-09-19
- Experiments with re-writable n-gram tables for LLM persistent memory — Mrinohk · 2026-09-19